KTC
HQL

Kistler-Tiffany Companies’s abrdn Life Sciences Investors HQL Stock Holding History

Kistler-Tiffany Companies’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,800
Closed -$49K – 663
2020
Q3 		$49K Buy
+2,800
New +$50.1K 0.02% 272

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Kistler-Tiffany Companies's HQL Position: Q4 2020 in Review

Kistler-Tiffany Companies sold out of abrdn Life Sciences Investors (HQL) in Q4 2020, closing a stake of 2,800 shares — an estimated $49K sold.

Kistler-Tiffany Companies first reported a position in HQL in Q3 2020 and held it in 1 quarter. The position peaked at $49K in Q3 2020. 66 funds tracked by Wall St. Rank hold HQL as of Q4 2020.

  • Kistler-Tiffany Companies reported no remaining abrdn Life Sciences Investors position as of Q4 2020 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 2,800 abrdn Life Sciences Investors shares in Q4 2020, an estimated $49K.
  • Kistler-Tiffany Companies first reported a position in abrdn Life Sciences Investors in Q3 2020 and held it in 1 quarter.
  • Kistler-Tiffany Companies's abrdn Life Sciences Investors position peaked at $49K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2020.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2020, filed 3 Feb 2021.